These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3430750)

  • 1. [Myelodysplastic syndromes (MDS) and their evolution].
    Yagura H; Mitsui H; Nakagawa M; Taoka T; Teshima H; Hiraoka A; Ueda T; Nakamura H; Shibata H; Masaoka T
    Rinsho Ketsueki; 1987 Aug; 28(8):1354-60. PubMed ID: 3430750
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myelodysplastic syndromes. A retrospective analysis of 72 cases. I. Clinical symptomatology and evolution].
    Avilés A; Romero N; García LD; Gómez J; González Llavén J
    Rev Invest Clin; 1988; 40(2):161-5. PubMed ID: 3175369
    [No Abstract]   [Full Text] [Related]  

  • 4. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
    Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
    Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered responses of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors in vitro: comparison with normal blast cells.
    Tohyama K; Ueda T; Yoshida Y; Nakamura T
    Exp Hematol; 1994 Jul; 22(7):539-45. PubMed ID: 7516887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do peripheral blasts count in myelodysplastic syndromes?
    Alhan C; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
    Leuk Res; 2009 Feb; 33(2):209-11. PubMed ID: 18640720
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of myelodysplastic syndromes with cytokines].
    Tohyama K; Ueda T; Tsutani H; Wano Y; Nakamura T
    Rinsho Ketsueki; 1993 Mar; 34(3):277-82. PubMed ID: 8479078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The myelodysplastic syndrome based on our cases].
    Bozóky G; Farkas L; Serényi P; Biliczki F
    Orv Hetil; 1986 Aug; 127(33):1993-8. PubMed ID: 3466134
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on blood and bone marrow findings of myelodysplastic syndromes: evaluation of proposals for classification of myelodysplastic syndromes.
    Yang CL; Li LQ; Chen WJ; Yang TY; Sun YM; Li XY
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(1):7-11. PubMed ID: 3174618
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.
    Orazi A; Cattoretti G; Heerema NA; Sozzi G; John K; Neiman RS
    Mod Pathol; 1993 Sep; 6(5):521-5. PubMed ID: 8248107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with primary myelodysplastic syndromes in a university haematology unit: report of five cases.
    Cheong SK; Ainoon O
    Med J Malaysia; 1987 Dec; 42(4):272-5. PubMed ID: 3454399
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.
    Pinto GR; Overal DJ; Moraes LS; Van Den Berg AV; Lemos JA; Smith Mde A; Burbano RR
    Genet Mol Res; 2005 Mar; 4(1):18-30. PubMed ID: 15841432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes.
    Buccisano F; Maurillo L; Tamburini A; Del Poeta G; Del Principe MI; Ammatuna E; Consalvo MI; Campagna S; Ottaviani L; Sarlo C; Renzi D; Faccia S; Fraboni D; Lo Coco F; Amadori S; Venditti A
    Eur J Haematol; 2008 Feb; 80(2):107-14. PubMed ID: 18028430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.
    Ohyashiki JH; Iwama H; Yahata N; Ando K; Hayashi S; Shay JW; Ohyashiki K
    Clin Cancer Res; 1999 May; 5(5):1155-60. PubMed ID: 10353751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis in patients with myelodysplastic syndromes based on cytomorphologic and clinico-biologic parameters].
    Belić A; Stefanović N; Pejin D; Mihajlović M; Popović S; Kljajić D; Uzurov V; Spasojević J
    Med Pregl; 1994; 47(7-8):237-42. PubMed ID: 7791674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes.
    Hu Q; Dey AL; Yang Y; Shen Y; Jilani IB; Estey EH; Kantarjian HM; Giles FJ; Albitar M
    Cancer; 2004 May; 100(9):1884-91. PubMed ID: 15112269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
    Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
    Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eosinophilic leukemia with myelofibrosis and dysplasia terminating in marked increase of blast cells: a report of an autopsied case].
    Yamada K; Horiuchi N; Shintani Y; Masuda K; Shinomiya S; Iishi Y; Kosaka M
    Rinsho Ketsueki; 1986 Oct; 27(10):1964-70. PubMed ID: 3820616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.